Free Trial

Genmab A/S (OTCMKTS:GNMSF) Stock Passes Above 50 Day Moving Average - Time to Sell?

Genmab A/S logo with Medical background

Shares of Genmab A/S (OTCMKTS:GNMSF - Get Free Report) passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $197.57 and traded as high as $218.13. Genmab A/S shares last traded at $218.13, with a volume of 6 shares traded.

Genmab A/S Stock Performance

The stock has a market capitalization of $14.41 billion, a P/E ratio of 12.45 and a beta of 0.92. The stock has a 50-day moving average price of $198.68 and a two-hundred day moving average price of $205.37.

Genmab A/S (OTCMKTS:GNMSF - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $3.05 earnings per share for the quarter, topping analysts' consensus estimates of $1.88 by $1.17. The firm had revenue of $765.14 million for the quarter, compared to analyst estimates of $761.09 million. Genmab A/S had a return on equity of 19.75% and a net margin of 36.30%.

Genmab A/S Company Profile

(Get Free Report)

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.

See Also

Should You Invest $1,000 in Genmab A/S Right Now?

Before you consider Genmab A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genmab A/S wasn't on the list.

While Genmab A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines